Compliance certificate submitted under SEBI DP Regulations for Sep 2026 quarter
AMRUTANJAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and 0.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Amrutanjan Health Care has submitted a compliance certificate under Regulation 74(5) of the SEBI Depositories and Participants Regulations 2018. The certificate was issued by its Registrar and Share Transfer Agent, Cameo Corporate Services Limited, for the quarter ended 30 September 2026. This is a standard quarterly filing confirming details of securities held in demat form.
Routine regulatory compliance filing with no material impact on the stock or shareholders.